Optimized expression cassettes for gene therapy
AssigneeTenaya Therapeutics, Inc.
InventorsHuanyu ZHOU, Christopher A. REID
Life of this patent
Estimating the term…
Loading patent…
AssigneeTenaya Therapeutics, Inc.
InventorsHuanyu ZHOU, Christopher A. REID
Estimating the term…
In some aspects, cardiac-specific expression cassettes are provided herein. In some aspects, provided herein is an expression cassette comprising a polynucleotide sequence encoding a gene product for therapy of a heart disease, wherein the polynucleotide sequence is operably linked to promoter (e.g., a cardiac-specific promoter), and optionally an enhancer (e.g., a cardiac-specific enhancer). In some aspects, the disclosure provides recombinant adeno-associated virus (rAAV) virions, comprising a capsid protein and a viral genome comprising an expression cassette comprising a polynucleotide sequence encoding a therapeutic gene product, e.g., dwarf open reading frame (DWORF) polypeptide, operably linked to a promoter, the expression cassette flanked by inverted terminal repeats. The disclosure further provides pharmaceutical compositions and methods of treating or preventing heart disease.
A method of treating a heart disease or disorder in a subject in need thereof, comprising administering to the subject a recombinant adeno-associated virus (rAAV) virion comprising (i) a capsid protein and (ii) a viral genome comprising an expression cassette, wherein the expression cassette comprises
A method of increasing dwarf open reading frame (DWORF) expression in a cell, tissue, or organ, comprising contacting the cell, tissue, or organ with a recombinant adeno-associated virus (rAAV) virion comprising (i) a capsid protein and (ii) a viral genome comprising an expression cassette, wherein the expression cassette comprises
Dependencies are inferred from the claim text.